PAREXEL International Corporation:企業の戦略・SWOT・財務分析

◆英語タイトル:PAREXEL International Corporation - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY4036
◆発行会社(調査会社):MarketLine
◆発行日:2020年2月
◆ページ数:46
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

PAREXEL International Corporation – Strategy, SWOT and Corporate Finance Report
Summary

PAREXEL International Corporation – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

PAREXEL International Corporation (PAREXEL or ‘the company’) is a leading global biopharmaceutical services provider. The company’s product and service portfolio include Clinical trials management, Biostatistical analysis, Pharmacovigilance, Clinical pharmacology, Regulatory information management (RIM) solutions, ClinPhone Randomization and trial supply management services (RTSM), Electronic data capture systems (EDC), Clinical trial management systems (CTMS), Regulatory information management (RIM) solutions, ClinPhone Randomization and trial supply management services (RTSM), Electronic data capture systems (EDC) and Clinical trial management systems (CTMS), among others. PAREXEL operates in the Americas, Europe, Asia Pacific, the Middle East and Africa. The company is headquartered in Waltham, Massachusetts, the US.

Scope

- Detailed information on PAREXEL International Corporation required for business and competitor intelligence needs
- A study of the major internal and external factors affecting PAREXEL International Corporation in the form of a SWOT analysis
- An in-depth view of the business model of PAREXEL International Corporation including a breakdown and examination of key business segments
- Intelligence on PAREXEL International Corporation’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about PAREXEL International Corporation, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of PAREXEL International Corporation and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess PAREXEL International Corporation as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on PAREXEL International Corporation’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
PAREXEL International Corporation: Company Overview
PAREXEL International Corporation: Overview and Key Facts
PAREXEL International Corporation: Overview
PAREXEL International Corporation: Key Facts
PAREXEL International Corporation: Key Employees
PAREXEL International Corporation: Key Employee Biographies
PAREXEL International Corporation: Major Products and Services
PAREXEL International Corporation: Company History
PAREXEL International Corporation: Locations and Subsidiaries
PAREXEL International Corporation: Key Competitors
PAREXEL International Corporation: Company Analysis
PAREXEL International Corporation: Business Description
PAREXEL International Corporation: SWOT Analysis
PAREXEL International Corporation: SWOT Overview
PAREXEL International Corporation: Strengths
PAREXEL International Corporation: Weaknesses
PAREXEL International Corporation: Opportunities
PAREXEL International Corporation: Threats
PAREXEL International Corporation: Corporate Financial Deals Activity
PAREXEL International Corporation: Financial Deals Overview
PAREXEL International Corporation: Targets and Partners
PAREXEL International Corporation: Top Deals 2016 – 2020YTD*
PAREXEL International Corporation: Advisors
PAREXEL International Corporation: Top Legal Advisors
PAREXEL International Corporation: Top Financial Advisors
PAREXEL International Corporation: Mergers and Acquisitions
PAREXEL International Corporation: Partnership
PAREXEL International Corporation: Private Equity and Ownership
PAREXEL International Corporation: Recent Developments
PAREXEL International Corporation: News and Events Summary
PAREXEL International Corporation: Business Expansion
PAREXEL International Corporation: Contracts
PAREXEL International Corporation: Corporate Governance
PAREXEL International Corporation: Financial Deals
PAREXEL International Corporation: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: PAREXEL International Corporation: Key Facts
Table 2: PAREXEL International Corporation: Key Employees
Table 3: PAREXEL International Corporation: Company History
Table 4: PAREXEL International Corporation: Locations and Subsidiaries
Table 5: PAREXEL International Corporation: Key Competitors
Table 6: PAREXEL International Corporation: Deal Activity by Deal Type - Volume (TTM*)
Table 7: PAREXEL International Corporation: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 8: PAREXEL International Corporation: Targets and Partners
Table 9: PAREXEL International Corporation: Top Deals 2016 - 2020YTD*
Table 10: PAREXEL International Corporation: Legal Advisor Ranking by Value (US$m)
Table 11: PAREXEL International Corporation: Financial Advisor Ranking by Value (US$m)
Table 12: PAREXEL International Corporation: M&A Volume and Value Trend (2016 - YTD*2020)
Table 13: PAREXEL International Corporation: M&A Activity by Geography (2016 - YTD*2020)
Table 14: PAREXEL International Corporation: Partnership Volume and Value Trend (2016 - YTD*2020)
Table 15: PAREXEL International Corporation: Partnership Trend by Deal Type (2016 - YTD*2020)
Table 16: PAREXEL International Corporation: Private Equity and Ownership Volume and Value Trend (2016 - YTD*2020)
Table 17: PAREXEL International Corporation: Private Equity and Ownership Volume by Deal Type (2016 - YTD*2020)
Table 18: PAREXEL International Corporation: News and Events Summary
Table 19: PAREXEL International Corporation: Business Expansion
Table 20: PAREXEL International Corporation: Contracts
Table 21: PAREXEL International Corporation: Corporate Governance
Table 22: PAREXEL International Corporation: Financial Deals
Table 23: PAREXEL International Corporation: Strategy and Operations

★海外企業調査レポート[PAREXEL International Corporation:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Virgin Group Ltd.:企業の戦略・SWOT・財務分析
    Virgin Group Ltd. - Strategy, SWOT and Corporate Finance Report Summary Virgin Group Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Haworth, Inc.
    Haworth, Inc. - Strategy, SWOT and Corporate Finance Report Summary Haworth, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Oral Health Products, Inc.:企業の戦略・SWOT・財務情報
    Oral Health Products, Inc. - Strategy, SWOT and Corporate Finance Report Summary Oral Health Products, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Kirin Holdings Co Ltd:戦略・SWOT・企業財務分析
    Kirin Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Kirin Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Kawasaki Kisen Kaisha, Ltd.:企業の戦略・SWOT・財務情報
    Kawasaki Kisen Kaisha, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Kawasaki Kisen Kaisha, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • KIYATEC Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary KIYATEC Inc (KIYATEC) is a biotechnology company that commercializes 3D cell culture technology. The company concentrates on data correlation to human clinical outcomes. It provides drug response profiling services for developing small molecule compounds and biologic drugs. KIYATEC offers cu …
  • Itausa – Investimentos Itau SA (ITSA4):企業の財務・戦略的SWOT分析
    Itausa - Investimentos Itau SA (ITSA4) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Svenska Cellulosa AB:戦略・SWOT・企業財務分析
    Svenska Cellulosa AB - Strategy, SWOT and Corporate Finance Report Summary Svenska Cellulosa AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • TechnipFMC Plc (FTI):企業の財務・戦略的SWOT分析
    TechnipFMC Plc (FTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Zynex Inc (ZYXI):医療機器:M&Aディール及び事業提携情報
    Summary Zynex Inc (Zynex), formerly Zynex Medical Inc is a medical technology company that designs, manufactures, and markets electrotherapy medical devices used for pain management and rehabilitation. The company’s products include NexWave, a dual channel, multi-modality interferential current, tra …
  • Kezar Life Sciences Inc-製薬・医療分野:企業M&A・提携分析
    Summary Kezar Life Sciences Inc (Kezar) is a biotech company that discovers and develops therapies for protein homeostasis. The company’s development program includes KZR-616, a selective small molecule inhibitor of the immunoproteasome. Its KZR-616 finds application in the treatment of autoimmune d …
  • The Reject Shop Ltd (TRS):企業の財務・戦略的SWOT分析
    The Reject Shop Ltd (TRS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Sanford Burnham Prebys Medical Discovery Institute-製薬・医療分野:企業M&A・提携分析
    Summary Sanford Burnham Prebys Medical Discovery Institute (Sanford Burnham) is a non-profit public benefit institute that offers medical research services. The institute offers research programs in the field of tumor initiation and maintenance, cancer metabolism and signaling networks, tumor microe …
  • Latam Airlines Group S.A.:企業の戦略・SWOT・財務分析
    Latam Airlines Group S.A. - Strategy, SWOT and Corporate Finance Report Summary Latam Airlines Group S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Feldan Bio Inc-製薬・医療分野:企業M&A・提携分析
    Summary Feldan Bio Inc (Feldan) is a biotechnology company. It discovers, develops, manufactures and markets research therapeutic and industrial protein products. The company offers cell therapy products, genome editing products and research products. Its genome editing product includes recombinant …
  • Inform Genomics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Inform Genomics Inc (Inform Genomics) manufactures and markets genomic-based personalized medicine products for cancer and supportive care. The company’s onpart is a medicinal product, which is used for the treatment of decisions in patients, who receive chemotherapy for colorectal, breast, …
  • Ferrellgas Partners LP (FGP):企業の財務・戦略的SWOT分析
    Summary Ferrellgas Partners LP (Ferrellgas) is an oil and gas company that supplies propane and related equipment. The company provides transportation, wholesale marketing, and distribution of propane. It also carries out selling refined fuels and feedstocks. Ferrellgas provides propane crop drying, …
  • PT Energi Mega Persada Tbk (ENRG):石油・ガス:M&Aディール及び事業提携情報
    Summary PT Energi Mega Persada Tbk (EMP) is an upstream oil and gas company that acquires, explores, develops and produces oil and gas from its assets. The company offers products such as crude oil and natural gas. It holds interests in a number of oil and gas blocks in Indonesia and Mozambique. EMP …
  • Helomics Corp-製薬・医療分野:企業M&A・提携分析
    Summary Helomics Corp(Helomics) is a life science company that develops and offers precision medicine support tools and services for cancer treatment. The company’s products include chemofx, biospecifx, genefx colon and genefx lung. Its chemofx is a drug response marker, which is used to test tumor …
  • Medikit Co Ltd (7749):企業の製品パイプライン分析
    Summary Medikit Co Ltd (Medikit) is a medical equipment provider that offers vascular devices. The company offers IV catheter, hemodialysis and intervention products. Its products include supercath Z3V, supercath 5 safety IV catheter, supercath AZ, supercath CLS, i-works, seiha, parent plus, parent …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆